5% stakes
Fairmount Funds Management
Institution
- 5% stake reports
- 25
- 5% stake stocks
- 10
- Latest report
- 26/09/11
5% stake reports
| Stock | ||
|---|---|---|
| Korsana Biosciences KRSA09/11 | 19.99%9,106,420 sh | First report |
| Crescent Biopharma CBIO07/20 | 16.52%6,602,408 sh | −2.0pp |
| Oruka Therapeutics ORKA07/01 | 19.5%14,572,917 sh | −0.5pp |
| Spyre Therapeutics SYRE06/23 | 9.99%9,667,201 sh | +0.0pp |
| Jade Biosciences JBIO06/09 | 19.99%14,069,494 sh | +0.0pp |
| Enliven Therapeutics ELVN05/15 | 3.1%1,855,644 sh | −3.2pp |
| Viridian Therapeutics, Inc.\DE VRDN05/13 | 14.04%17,201,800 sh | −1.1pp |
| Oruka Therapeutics ORKA05/04 | 19.99%13,665,080 sh | +0.0pp |
| Spyre Therapeutics SYRE04/20 | 9.99%9,016,702 sh | +0.0pp |
| Cogent Biosciences COGT03/31 | 8.6%15,356,918 sh | −1.3pp |
| Damora Therapeutics DMRA02/11 | 19.99%8,713,000 sh | +0.0pp |
| Cogent Biosciences COGT01/22 | 9.9%16,261,918 sh | +0.0pp |
| Crescent Biopharma CBIO25/12/08 | 18.53%5,643,482 sh | −1.5pp |
| Dianthus Therapeutics DNTH25/11/25 | 4.9%2,139,635 sh | −5.0pp |
| Damora Therapeutics DMRA25/11/17 | 19.99%397,000 sh | First report |
| Cogent Biosciences COGT25/11/17 | 9.9%15,877,418 sh | +0.0pp |
| Viridian Therapeutics, Inc.\DE VRDN25/10/27 | 15.14%16,025,330 sh | No earlier report |
| Spyre Therapeutics SYRE25/10/17 | 9.99%8,106,882 sh | No earlier report |
| Jade Biosciences JBIO25/10/08 | 19.99%10,353,875 sh | +0.0pp |
| Oruka Therapeutics ORKA25/09/19 | 19.99%11,162,741 sh | +0.0pp |
